Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1999;81:25-32; doi:10.1136/hrt.81.1.25
Copyright © 1999 BMJ Publishing Group Ltd & British Cardiovascular Society

Heart 1999;81:25-32 ( January )

beta Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study

K S Spargias,a A S Hall,a D C Greenwood,b S G Balla

a Institute for Cardiovascular Research, University of Leeds, Leeds LS2 9JT, UK, b Subunit for Medical Statistics, University of Leeds

Correspondence to: Dr Hall.

Accepted for publication 29 July 1998

Objectives---To examine clinical outcomes associated with optional beta  blockade in a population of patients with evidence of heart failure after myocardial infarction.
Design and patients---Data from the acute infarction ramipril efficacy (AIRE) study were analysed retrospectively. At baseline 22.3% of the patients were receiving a beta  blocker. To minimise confounding, beta  blocker and diuretic treatments, presence of clinical signs of heart failure, left ventricular ejection fraction, and 16 other baseline clinical variables were simultaneously entered in a multivariate Cox regression model. In addition, the same analysis was repeated separately within a high and a low risk group of patients, as defined according to the need for diuretic treatment.
Results---beta Blocker treatment was an independent predictor of reduced risk of total mortality (hazard ratio 0.66, 95% confidence interval (CI) 0.48 to 0.90) and progression to severe heart failure (0.58, 95% CI 0.40 to 0.83) for the entire study population. There were similar findings in high risk patients requiring diuretics (0.59, 95% CI 0.40 to 0.86; and 0.58, 95% CI 0.38 to 0.89).
Conclusions---beta Blocker treatment is associated with improved outcomes in patients with clinical evidence of mild to moderate heart failure after myocardial infarction. Most importantly, high risk patients with persistent heart failure appear to benefit at least as much as lower risk patients with transient heart failure.

Keywords: myocardial infarction;  heart failure;  left ventricular dysfunction;  beta blockers


© 1999 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Radford, M. J. (2006). Percutaneous Coronary Intervention "Dominates" Coronary Artery Bypass Graft Surgery for High-Risk Patients: Good News for Patients, a Challenge for Healthcare Planners. Circulation 114: 1229-1231 [Full Text]  
  • Gheorghiade, M., Goldstein, S. (2002). {beta}-Blockers in the Post-Myocardial Infarction Patient. Circulation 106: 394-398 [Full Text]  
  • Tjeerdsma, G., Szabo, B. M., van Wijk, L. M., Brouwer, J., Tio, R. A., Crijns, H. J.G.M., van Veldhuisen, D. J. (2001). Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on {beta}-blockade. Eur J Heart Fail 3: 33-39 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.